Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sugi Holdings CoSGIPF 83 3-Year EBITDA Growth Rate is 17.70% as of Feb. 2026, which is 172% above its 10-year median of 6.50. GuruFocus rates SGIPF with a GF Score™ of 83/100 and a GF Value™ of $15.30 (Modestly Overvalued). The stock has 3 warning signs investors should review. Among 526 Healthcare Providers & Services companies, Sugi Holdings Co ranks better than 63.31% on this metric.
During the past 12 months, Sugi Holdings Co's average EBITDA Per Share Growth Rate was 17.80% per year.
During the past 3 years, the average EBITDA Per Share Growth Rate was 17.70% per year.
During the past 5 years, the average EBITDA Per Share Growth Rate was 11.40% per year.
During the past 10 years, the average EBITDA Per Share Growth Rate was 8.80% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Sugi Holdings Co was 31.90% per year. The lowest was 0.30% per year. And the median was 6.50% per year.
Sugi Holdings Co (OTCPK:SGIPF) 3-Year EBITDA Growth Rate Explanation
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
Sugi Holdings Co 3-Year EBITDA Growth Rate Related Terms
Sugi Holdings Co 3-Year EBITDA Growth Rate Competitor Comparison
For the Pharmaceutical Retailers subindustry, Sugi Holdings Co's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sugi Holdings Co 3-Year EBITDA Growth Rate vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Sugi Holdings Co's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where Sugi Holdings Co's 3-Year EBITDA Growth Rate falls into.
Sugi Holdings Co 3-Year EBITDA Growth Rate Calculation
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of 17.70% mean?
Sugi Holdings Co (SGIPF) has a 3-Year EBITDA Growth Rate of 17.70% as of Feb. 2026. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Sugi Holdings Co and its competitors. This is 172% above median its historical median of 6.50. Over the past decade, Sugi Holdings Co's 3-Year EBITDA Growth Rate has ranged from 0.30 to 31.90. According to the industry distribution chart, Sugi Holdings Co ranks #193 out of 526 companies in the Healthcare Providers & Services industry, placing it in the top 36.7%.
Is Sugi Holdings Co's 3-Year EBITDA Growth Rate too high?
Sugi Holdings Co's current 3-Year EBITDA Growth Rate of 17.70% is 172% above median its 10-year median of 6.50. Over the past 10 years, this metric has ranged from a low of 0.30 to a high of 31.90. The Healthcare Providers & Services industry median 3-Year EBITDA Growth Rate is 10.05. Sugi Holdings Co's value of 17.70% is 76.1% above this industry median. Based on the distribution chart, Sugi Holdings Co ranks #193 out of 526 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Sugi Holdings Co has a GF Score™ of 83/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Sugi Holdings Co's 3-Year EBITDA Growth Rate compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Sugi Holdings Co ranks #193 out of 526 companies for 3-Year EBITDA Growth Rate. This puts Sugi Holdings Co in the upper half of its industry. The industry median 3-Year EBITDA Growth Rate is 10.05. Sugi Holdings Co's value of 17.70% is 76.1% above this benchmark. Historically, Sugi Holdings Co's own 3-Year EBITDA Growth Rate has ranged from 0.30 to 31.90 over the past decade. While the company's 10-year median is 6.50 vs. the industry median of 10.05, Sugi Holdings Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Healthcare Providers & Services company?
The median 3-Year EBITDA Growth Rate among Healthcare Providers & Services companies is 10.05, based on 526 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sugi Holdings Co's current 3-Year EBITDA Growth Rate of 17.70% is 76.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Sugi Holdings Co and its competitors. For the Healthcare Providers & Services industry, the median 3-Year EBITDA Growth Rate is 10.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sugi Holdings Co's current 3-Year EBITDA Growth Rate is 17.70%, which is 172% above median its own 10-year median of 6.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sugi Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, Sugi Holdings Co (SGIPF) is currently considered Modestly Overvalued. The stock's GF Value™ is $15.30, compared to a current price of $18.99 — trading 24.1% above its estimated fair value. The current 3-Year EBITDA Growth Rate is 17.70%, which is 172% above median its 10-year median of 6.50 and 76.1% above the Healthcare Providers & Services industry median of 10.05. Sugi Holdings Co's overall GF Score™ is 83/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For Sugi Holdings Co (SGIPF), the current 3-Year EBITDA Growth Rate is 17.70% as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sugi Holdings Co (SGIPF) Overvalued in 2026?
Based on GuruFocus' analysis, Sugi Holdings Co stock appears to be overvalued.
The current stock price of $18.99 is trading 24.1% above its estimated GF Value™ of $15.30.
GuruFocus considers Sugi Holdings Co to be Modestly Overvalued.
Key valuation signals for SGIPF:
3-Year EBITDA Growth Rate: 17.70% (172% above median its 10-year median of 6.50)
GF Value™: $15.30 vs. price of $18.99 (24.1% above fair value)
Industry Position: 76.1% above the Healthcare Providers & Services median (#193 of 526)
No single metric tells the full story. See the SGIPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sugi Holdings Co Ltd is a Japan-based company engaged in drugstore operations and the pharmaceutical dispensing business. Through its subsidiaries, the company is involved in selling pharmaceuticals, health foods, cosmetics, daily essentials, and prescription drugs. It also operates community-based drugstores that support home healthcare in collaboration with local medical professionals. The company also supports regional healthcare facilities and provides at-home nursing services.
83GF Score
Get the complete analysis for SGIPF
3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SGIPF has been successfully added to your 
